汇添富恒生生物科技ETF(QDII)(513280)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-15,927,280.10 |
-40,046,387.38 |
-13,382,659.29 |
-13,071,295.52 |
利息合计 |
54,497.55 |
14,500.35 |
18,749.49 |
8,311.41 |
其中:存款利息收入 |
54,497.55 |
14,500.35 |
18,749.49 |
8,311.41 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-10,860,332.95 |
-6,215,938.70 |
-1,425,909.32 |
2,416,257.62 |
其中:股票投资收益 |
-13,599,540.73 |
-7,669,718.76 |
-2,393,685.22 |
1,945,295.56 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
- |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
2,739,207.78 |
1,453,780.06 |
967,775.90 |
470,962.06 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
-5,900,652.73 |
-33,656,576.84 |
-11,424,925.42 |
-15,169,707.94 |
其他收入 |
1,503,713.81 |
686,489.61 |
672,319.10 |
326,969.11 |
费用 |
516,241.27 |
234,301.74 |
356,102.64 |
165,895.28 |
管理人报酬 |
260,760.77 |
111,104.49 |
139,998.46 |
61,357.23 |
基金托管费 |
86,920.23 |
37,034.83 |
46,666.14 |
20,452.37 |
销售服务费 |
- |
- |
- |
- |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
168,560.27 |
86,162.42 |
169,438.04 |
84,085.68 |
利润总额 |
-16,443,521.37 |
-40,280,689.12 |
-13,738,761.93 |
-13,237,190.80 |